Dr. Jorge E. Corso, M.D.
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 858
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: Medical College of Georgia School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
GA license 054603
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cleveland Clinic Cleveland, OH
- Hillcrest Hospital Mayfield Heights, OH
- Fairview Hospital Cleveland, OH
- Cleveland Clinic Avon Hospital Avon, OH
- Lutheran Hospital Cleveland, OH
Medical groups
- Cleveland Clinic (7,090 clinicians)
- Wooster Clinic LLC (299 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 858
- Services billed
- 1,301
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Ultrasound of both sides of head and neck blood flow | 263 | 262 |
| Ultrasound study of arm and leg arteries | 155 | 149 |
| Established patient office or other outpatient visit, 30-39 minutes | 141 | 125 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 102 | 101 |
| Established patient office or other outpatient visit, 20-29 minutes | 94 | 90 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 81 | 81 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 76 | 75 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 67 | 66 |
| Complete ultrasound study of arm and leg arteries | 53 | 52 |
| New patient office or other outpatient visit, 45-59 minutes | 40 | 40 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Atlanta, GA | 49 |
| Eliquis (apixaban) Other prescribers in Atlanta, GA | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 29 payments worth $7,979 in total to this clinician.
| Endologix LLC | $4,718 |
|---|---|
| Abbott Laboratories | $2,369 |
| Medtronic, Inc. | $290 |
| Reflow Medical Inc | $232 |
| W. L. Gore & Associates, Inc. | $206 |
| Shockwave Medical, Inc | $105 |
| Penumbra, Inc. | $22.39 |
| Boston Scientific Corporation | $20.90 |
| Consulting Fee | $3,713 |
|---|---|
| Food and Beverage | $2,224 |
| Travel and Lodging | $2,043 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Endologix LLC Dec 17, 2025 | Consulting Fee Alto Abdominal Stent Graft System · Cardiology/Vascular Diseases Company’s description53312 | $2,700 |
| Abbott Laboratories Nov 7, 2025 | Travel and Lodging ACCULINK · Vascular · travel to New York, NY · in-kind | $1,150 |
| Endologix LLC May 21, 2025 | Consulting Fee Torus Stent Graft System; ENDOCROSS Device; Alto Abdominal Stent Graft System · Cardiology/Vascular Diseases Company’s description51526 | $1,013 |
| Abbott Laboratories Nov 7, 2025 | Travel and Lodging ACCULINK · Vascular · travel to New York, NY · in-kind | $461 |
| Abbott Laboratories Nov 26, 2025 | Travel and Lodging ACCULINK · Vascular · travel to New York, NY · in-kind | $422 |
| Abbott Laboratories Nov 26, 2025 | Travel and Lodging ACCULINK · Vascular · travel to New York, NY · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,100 in research payments for these studies, mostly to the institutions running them.
- A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis
M.a. Med Alliance S.a.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.